Search research articles
Contact Us
Filters
Showing results (201-210 of 347) with videos related to
Page
of 35
Sort By:
International Journal of Cancer
|
April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
Eva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 18, 2016
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study
Amit M Oza, Frédéric Selle, Irina Davidenko, et al.
Medicine and Science in Sports and Exercise
|
July 26, 2022
Supervised Physical Activity Quickly Improves Social Dimension of Quality of Life in Breast Cancer Patients
Anaïs Briant, Charline Frandemiche, Emmanuel Sevin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2012
Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer
Nicoletta Colombo, Elzbieta Kutarska, Meletios Dimopoulos, et al.
The Oncologist
|
June 24, 2018
Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer
Marie Lange, Natacha Heutte, Sabine Noal, et al.
Bulletin Du Cancer
|
January 30, 2026
[French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer]
Cyrus Chargari, Alejandra Martinez, Judith Michels, et al.
Molecular Oncology
|
April 17, 2016
Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy
Nicolas Vigneron, Matthieu Meryet-Figuière, Audrey Guttin, et al.
Familial Cancer
|
October 27, 2016
BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer
Estelle Jamard, Bertrand Volard, Audrey Emmanuelle Dugué, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
Eric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2018
Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer
Claudia S E W Schuurhuizen, Patricia Marino, Annemarie M J Braamse, et al.
Page
of 35
Search research articles
Search
Showing results (201-210 of 347) with videos related to
Sort By:
Page
of 35
International Journal of Cancer
|
April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
Eva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 18, 2016
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study
Amit M Oza, Frédéric Selle, Irina Davidenko, et al.
Medicine and Science in Sports and Exercise
|
July 26, 2022
Supervised Physical Activity Quickly Improves Social Dimension of Quality of Life in Breast Cancer Patients
Anaïs Briant, Charline Frandemiche, Emmanuel Sevin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2012
Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer
Nicoletta Colombo, Elzbieta Kutarska, Meletios Dimopoulos, et al.
The Oncologist
|
June 24, 2018
Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer
Marie Lange, Natacha Heutte, Sabine Noal, et al.
Bulletin Du Cancer
|
January 30, 2026
[French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer]
Cyrus Chargari, Alejandra Martinez, Judith Michels, et al.
Molecular Oncology
|
April 17, 2016
Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy
Nicolas Vigneron, Matthieu Meryet-Figuière, Audrey Guttin, et al.
Familial Cancer
|
October 27, 2016
BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer
Estelle Jamard, Bertrand Volard, Audrey Emmanuelle Dugué, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2010
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
Eric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2018
Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer
Claudia S E W Schuurhuizen, Patricia Marino, Annemarie M J Braamse, et al.
Page
of 35